Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sus scrofa

ABSTRACT: PPARD is a critical inhibitor of cartilage growth in external ears [ChIP-Seq]

PROVIDER: PRJNA357364 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5109950.fastq.gz	Fastqsanger.gz
	SRR5109949.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Sus scrofa

Project description:PPARD is a critical inhibitor of cartilage growth in external ears [RNA-Seq]

| PRJNA357363 | ENA

PPARD is a critical inhibitor of cartilage growth in external ears

Project description:PPARD is a critical inhibitor of cartilage growth in external ears

| PRJNA357365 | ENA

PPARD is a critical inhibitor of cartilage growth in external ears [RNA-Seq]

Project description:In this study, we uncover the molecular mechanism that PPARD transactive-deficient pigs have large-eared feature. Evidently from this work, PPARD plays a vital role on inhibiting cartilage growth by regulating the transcription of critical genes for chondrogenesis in ligand dependent manner; the activation of sPPARD speeds up apoptosis in CSPCs, terminal differentiation of chondroblasts and matrix degradation in auricular cartilage. The transactive-deficient PPARD has not the capability to slow down cartilage growth and consequently causes that ear size of carried animals increases at a high growth rate. As the role of PPARD in cartilage is similar in pigs, mice and humans, and since cartilage development is well-conserved in animals, our data helps to better understanding of cartilage development and treatment of cartilage-related diseases.

2017-06-09 | GSE92373 | GEO

PPARD is a critical inhibitor of cartilage growth in external ears [ChIP-Seq]

2017-06-09 | GSE92370 | GEO

Sus scrofa

Project description:Expression data from articular and growth plate cartilage

| PRJNA131031 | ENA

Expression data from Sus scrofa atria

Project description:Regulatory Mechanisms of Atrial Remodeling of Mitral Regurgitation Pigs This study enrolled 6 pigs (age: 18 months) and divided into three groups: mitral regurgitation pigs (MR) (n = 2; 2 males sacrificed 12 months after surgery), MR pigs treated with valsartan (MRV) (n = 2; 2 males age-matched to MR sacrificed 12 months after surgery), and normal control pigs (NC) (n = 2; 2 males age-matched to MR pigs). Valsartan (3.43 mg/kg/day), a type I angiotensin II receptor blocker, was administered from one week before surgery and then daily after surgery in the MRV group. We sought to systemically elucidate critical differences in the alteration of RNA expression pattern between the atrial myocardium of pigs with and without MR, and between the atrial myocardium of MR pigs with and without valsartan using high-density oligonucleotide microarrays and functional network enrichment analysis.

2015-02-01 | E-GEOD-43072 | biostudies-arrayexpress

DH06 Adrenal ACTH Sus scrofa

Project description:Large White and Meishan pigs were either non-treated or injected with mammalian 1-24 ACTH (Immediate Synachten, Novartis France) at the dose of 250 µg per animal. Pigs were sacrificed either immediately after capture from their home cage (non-treated animals) or 1 hour following ACTH injection. Adrenal glands were immediately collected from pigs and frozen on dry ice and then stored at -80°C until RNA isolation. Keywords: stress response, adrenal, gene expression, pig

2008-01-07 | GSE8377 | GEO